Thoracic Guidelines
The neoadjuvant chemoimmunotherapy pathway has become the standard of care for patients with resectable, locally advanced non-small cell lung cancer without actionable mutations. Its increasing use has introduced novel technical challenges, as fibrotic changes, inflammatory...
…This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Bart P. van Putte, a cardiothoracic surgeon at the St. Antonius Hospital in Nieuwegein, Netherlands, and the Amsterdam University...
A 27-year-old male previously underwent bilateral T2–T3 sympathicotomy for severe palmar hyperhidrosis. Compensatory hyperhidrosis involving the trunk developed one year after the initial procedure and progressively became debilitating. Seven years...
This article explores the complexities of determining resectability in patients with non-small cell lung cancer (NSCLC). The authors emphasize that resectability, crucial for deciding treatment pathways, is best assessed by...
A condensed, granular and yet comprehensive discussion on a small retrospective series on mostly non-iatrogenic trauma of the subclavian and axillary arteries treated mostly by stenting. Professor Veller’s viewpoint is...
